To the Editor We read the article by Yousef et al titled “Intra-arterial Chemotherapy for Retinoblastoma: A Systematic Review.”1 From our perspective from an intra-arterial chemotherapy (ophthalmic artery chemosurgery [OAC]) program in Argentina, we believe that some issues limit the validity of their conclusions regarding the risk of metastatic relapse.